SCHEMBL17875801

SCHEMBL17875801

c1ccc(-c2cc(-c3ccc4c(c3)-c3cc(-c5cccc6oc7ccccc7c56)ccc3CSC4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.34
ENPP3 O14638 2/20 0.32
ALOX5 P09917 1/20 0.32
MAPK1 P28482 3/20 0.32
KMT2A Q03164 2/20 0.32
MYC P01106 1/20 0.32
MAPT P10636 3/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 2/20 0.31
TDP1 Q9NUW8 1/20 0.31
PLA2G2A P14555 3/20 0.31
PLA2G4A P47712 3/20 0.31
PLA2G10 O15496 1/20 0.31
PRKDC P78527 1/20 0.31
PLAUR Q03405 1/20 0.30
MEN1 O00255 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
CSNK2A2 P19784 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875765 0.96 BACE1 (0.32) BACE1ENPP3ALOX5MAPK1KMT2A
SCHEMBL17875773 0.96 BACE1 (0.32) BACE1ENPP3ALOX5MAPK1KMT2A
SCHEMBL17875806 0.90 PLA2G2A (0.39) BACE1ALOX5KMT2AMAPTALDH1A1
SCHEMBL17875780 0.88 ALOX5 (0.46) ENPP3ALOX5PRKDCCSNK2A2CSNK2B
SCHEMBL17875909 0.88 HSP90AA1 (0.38) BACE1ENPP3ALOX5MAPK1KMT2A
SCHEMBL17875783 0.88 HCRTR1 (0.36) MAPK1KMT2AMYCMAPTALDH1A1
SCHEMBL17875798 0.88 KMT2A (0.38) MAPK1KMT2AMYCMAPTALDH1A1
SCHEMBL17875804 0.87 ALOX5 (0.40) BACE1ALOX5KMT2AMAPTALDH1A1
SCHEMBL17875762 0.86 PLA2G2A (0.36) BACE1ALOX5KMT2AMAPTL3MBTL1
SCHEMBL17875746 0.86 PLA2G2A (0.36) BACE1ALOX5KMT2AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 BACE1 709/4885ENPP3 2678/4885ALOX5 3059/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 BACE1 709/4885ENPP3 2678/4885ALOX5 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.